Thank you, Sascha. Before I take you through our Q1 financial performance, I would just like to personally thank Leon for all this years of hard work and devotion to Microvast. I am fortunate to inherit from him a great finance team that has global reach and capabilities. Additionally, Leon leaves me with a very strong balance sheet and an orderly and clean capital structure. As you know, we have exciting plans for our capital deployment over the next couple of years and beyond. And I'm excited by the opportunities that lay ahead for the company. Now, let me turn to our financials and I'll spend the next few minutes discussing our Q1, 2022 financial results. Please turn to Slide 10. And I will summarize the main line items from our Q1 P&L. First off revenue, I am pleased to report strong revenue growth in the first quarter, which grew 145.5% to $36.7 million from $14.9 million in Q1, 2021. As Sascha mentioned, this performance exceeded our expectations. And I will take you through the geographic breakdown in a later slide. We posted gross profit of $13,000 in Q1, 2022 compared to gross loss of $1.2 million in the prior period. After adjusting for non-cash settled share-based compensation expense, adjusted gross profit was $1.9 million in Q1, 2022 compared to adjusted gross loss of $1.2 million in Q1, 2021. This translates into an adjusted gross margin of 5.2% in Q1, 2022 compared to negative 8.3% in Q1 2021 a 13.5 percentage point improvement. Operating expenses were $43.4 million in Q1, 2022 compared to $11.5 million in the prior year period. The largest contributor to the increased operating expenses was share-based compensation expense, which totaled $26.2 million in the quarter. of this SBC expense $14.3 million is non-cash, and the balance is currently expected to be settled in cash this year. Operating expenses also increases the company added headcounts support the planned growth initiatives and also incurred additional expenses related to operating as a public company compared to the prior year period. Net loss was $43.8 million in Q1, 2022 compared to net loss of $16.3 million in Q1, 2021. After adjusting for non-cash settled share-based compensation expense, and changes in fair value of our warrant liability, and convertible notes, adjusted net loss was $29.1 million in Q1, 2022 compared to $12.7 million in Q1, 2021. Adjusted EBITDA was negative $23.1 million in Q1, 2022 compared to negative $6 million in Q1, 2021. Reconciliations of these non-GAAP metrics to the most comparable GAAP metrics are included in the table at the end of our earnings press release. Slide 11 further illustrates the impact of these adjustments. As I just mentioned, we have substantial SBC expenses in Q1 of $26.2 million that is primarily related to stock option and kept RSU awards under a plan that pre-existed our [indiscernible] merger. Because of the modification made to these awards, we are required under GAAP to expense it to our P&L over a three year period starting from July 23, 2021. We have adopted a prudent approach of only adjusting for the non-cash settled portion of this SBC expense. Slide 12 shows a geographic breakdown of our revenue in Q1 this year compared to last year. As you can see on a percentage basis, the biggest growth was in Asia Pacific, ex China, at a growth of 628% year-over-year. As Sascha mentioned, this was primarily driven by deliveries to leading OEM customers in India. It is worth noting that our China Business still posted an 86% year-over-year growth. And we expect that while this will remain a growing market for us, we currently expect the contributions from customers in Asia Pacific, Europe and the U.S. to grow at a faster rate. I will now take you through our funding position and the cash movement in Q1, 2022 which is on Slide 13. We started the quarter with $536 million in cash, cash equivalents and restricted cash. Net cash used in operating activities during the quarter was $24.9 million, which was primarily due to increased notes receivable and inventory due to our higher sales, as well as the management decision to pay for certain raw materials earlier than usual in order to secure lower prices from our suppliers. Our CapEx spend on Huzhou 3.1 million and Clarkesville 1.1 million was $38 million during the quarter. And we also invested a further $2 million into our existing facilities and R&D. This gives us approximately $470.7 million in cash, cash equivalents and restricted cash at the end of Q1. Management estimates for our total capital expenditures in 2022 remain in the region of $300 million to $350 million, with most of this being allocated to our capacity expansion projects, which will bring online an additional four gigawatt hours of capacity per annum. These expansions, which are our growth drivers for the coming years, are fully funded from our current balance sheet capacity. We will also be opportunistic to bring in bank financing. We have a growing fixed asset base is unencumbered and our current debt levels are very low. As regards the asset base, our capacity expansions are underpinned by our large and growing forecasts or contracted revenues, which will bring incremental cash flows in the future. To round off, we closed the quarter in a very strong cash position, and with flexibility across our balance sheet and capital structure to raise more capital that will be done at a time that best suits us and as it's needed to support future growth beyond our current four gigawatt hour expansion. With that, I will turn it back over to Sascha to review the outlook.